These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15299161)

  • 1. A case of two adverse reactions.
    Smith LA; Harkness M
    Postgrad Med J; 2004 Aug; 80(946):484-6. PubMed ID: 15299161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic reactions to enoxaparin and heparin: a case report and review of the literature.
    Tiu A; Pang JM; Martin R; Officer N
    N Z Med J; 2004 Oct; 117(1204):U1126. PubMed ID: 15505672
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
    Lopes RD; Alexander KP; Marcucci G; White HD; Spinler S; Col J; Aylward PE; Califf RM; Mahaffey KW
    Eur Heart J; 2008 Aug; 29(15):1827-33. PubMed ID: 18519426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced recurrent anaphylaxis.
    Berkun Y; Haviv YS; Schwartz LB; Shalit M
    Clin Exp Allergy; 2004 Dec; 34(12):1916-8. PubMed ID: 15663568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life-threatening severe allergic reactions: urticaria, angioedema, and anaphylaxis.
    Lipozencić J; Wolf R
    Clin Dermatol; 2005; 23(2):193-205. PubMed ID: 15802213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H; Hammerstingl C; Paar WD;
    Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful heparin desensitization after anaphylactic shock due to heparin.
    Altintaş ND; Aybar Türkoğlu M; Bozkurt B; Topeli Iskit A; Karakaya G; Kalyoncu AF
    Tuberk Toraks; 2009; 57(1):68-72. PubMed ID: 19533440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anaphylactic shock].
    Müller-Werdan U; Werdan K
    Wien Klin Wochenschr; 2000 Feb; 112(4):149-56. PubMed ID: 10726327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options.
    Bircher AJ; Harr T; Hohenstein L; Tsakiris DA
    Allergy; 2006 Dec; 61(12):1432-40. PubMed ID: 17073874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eczema-like plaques secondary to enoxaparin.
    White JM; Munn SE; Seet JE; Adams N; Clement M
    Contact Dermatitis; 2006 Jan; 54(1):18-20. PubMed ID: 16426288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholesterol crystal embolisation in the course of treatment with low-molecular-weight heparins].
    Calotă F; Vîlcea D; Intorcaciu M; Pâirvănescu H; Enache D; Comănescu V; Vasile I; Scurtu S
    Chirurgia (Bucur); 2005; 100(6):605-8. PubMed ID: 16553203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enoxaparin-induced hemorrhagic bullous dermatosis in a leprosy patient.
    Öztürk S; Can I; Erden I; Akyol H; Solmaz OA
    Cutan Ocul Toxicol; 2015; 34(3):254-6. PubMed ID: 25198402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
    Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylactic reactions in children--a questionnaire-based survey in Germany.
    Mehl A; Wahn U; Niggemann B
    Allergy; 2005 Nov; 60(11):1440-5. PubMed ID: 16197479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retroperitoneal bleed induced by enoxaparin therapy.
    Ernits M; Mohan PS; Fares LG; Hardy H
    Am Surg; 2005 May; 71(5):430-3. PubMed ID: 15986976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fatal case of enoxaparin induced skin necrosis and thrombophilia.
    Nadir Y; Mazor Y; Reuven B; Sarig G; Brenner B; Krivoy N
    Eur J Haematol; 2006 Aug; 77(2):166-8. PubMed ID: 16856910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis during anaesthesia: diagnosis and treatment.
    Soetens FM
    Acta Anaesthesiol Belg; 2004; 55(3):229-37. PubMed ID: 15515300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin-associated fat necrosis of the breast.
    Das AK
    Age Ageing; 2005 Mar; 34(2):193-4. PubMed ID: 15713870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.